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A B S T R A C T   
Diffuse alveolar hemorrhage (DAH) is a rare life-threatening condition in children. In this entity, the bleeding 
originates from the pulmonary microvasculature as a result of microvascular damage leading to blood leakage 
into the alveolar spaces. DAH can occur as an isolated medical entity or may be associated with other organ 
system injury or dysfunction. The classic triad of symptoms includes hemoptysis, anemia and diffuse pulmonary 
infiltrates. Hemoptysis is the usual presenting symptom but is not constant. A variety of diseases is associated 
with the development of DAH. Current classification organize the etiologies of diffuse alveolar hemorrhage based 
on the presence of severe immune disorders (such as systemic vasculitis and collagenosis) or non- 
immunodeficiency disorders (with an identified cardiac or non-cardiac origin, or idiopathic). 
The five cases of DAH presented in this study were all diagnosed in full-term infants, four males and one 
female, with normal neonatal adaptation and without family history of notable diseases. In all cases the diagnosis 
was made between the age of three and eighteen weeks-old. Moreover, all five patients, at the time of diagnosis, 
presented with hemoptysis, mild or severe dyspnea, anemia and abnormal chest X-rays. Consequently, the 
diagnosis of DAH was strongly suspected and, eventually, confirmed by bronchoscopy. Additional laboratory 
tests, as well as selected serologic and radiographic studies were performed in order to identify a specific eti-
ology. The final diagnoses reflect a variety of causes: infections, idiopathic pulmonary hemosiderosis, accidental 
suffocation and Heiner syndrome. Treatment included oral corticosteroids except from one patient that received 
antimicrobial therapy.   
1. Background 
DAH is a rare but potentially life-threatening condition in infants. In 
this entity, the bleeding originates from the pulmonary microvascula-
ture (pulmonary arterioles, alveolar capillaries, and pulmonary venules) 
as a result of microvascular damage leading to blood leakage into the 
alveolar spaces [19,23]. 
Due to the lack of reported cases and cohorts described in the liter-
ature, the epidemiology and the incidence of the different causes of DAH 
in pediatric population remain imprecise. 
A variety of diseases is associated with the development of the DAH. 
Current classification schemes organize the etiologies of DAH according 
to the association with severe immune disorders (such as systemic 
vasculitis and collagenosis [19]), the association with non-immune 
disorders, which may be of cardiac or non-cardiac origin, or idiopathic 
disorders [1,2]. In children, the most frequent non-immune causes of 
DAH are infections [22] and cardiovascular diseases. 
Interestingly, a plethora of cases of DAH in children have been 
identified as idiopathic pulmonary hemosiderosis (IPH). IPH is a diag-
nosis of exclusion, and its pathogenesis remains controversial [10,23]. 
Various hypotheses have been proposed to explain the pathophysiology 
of IPH; allergic, environmental, genetic and autoimmune [9,10]. The 
allergic theory is based on the frequent association between IPH and 
cow’s milk hypersensitivity (Heiner syndrome). 
Published data associating pulmonary hemosiderosis with the 
exposure to a toxigenic fungus provides some evidence that environ-
mental factors may play a role in DAH [11]. IPH has also been described 
in a small number of familial cases, leading to the discussion of a genetic 
theory; however, no gene has been identified yet [12]. Finally, consid-
ering the frequent association with autoimmune diseases, the autoim-
mune theory is recognized as the most probable. It is important to 
mention that alveolar hemorrhage may be the first manifestation 
* Corresponding author. 
E-mail address: efthymia.gkogkou@student.uliege.be (E. Gkogkou).  
Contents lists available at ScienceDirect 
Respiratory Medicine Case Reports 
journal homepage: http://www.elsevier.com/locate/rmcr 
https://doi.org/10.1016/j.rmcr.2020.101121 
Received 6 April 2020; Received in revised form 6 June 2020; Accepted 7 June 2020   
Respiratory Medicine Case Reports 31 (2020) 101121
2
occurring well before (months to a year) the development of an immu-
nological disorders [14,19,24]. Table 1 demonstrates the current clas-
sification scheme for the causes of DAH. 
2. Clinical manifestations, laboratory findings and imaging 
The clinical presentation of DAH can vary from acute respiratory 
distress syndrome to a more insidious presentation with minimal 
symptoms such as cough. The classic triad of symptoms includes he-
moptysis, anemia and diffuse pulmonary infiltrates [21]. Hemoptysis is 
the usual presenting symptom, but is not constant, as young children 
may not expectorate [2,10]. 
3. Diagnostic approach 
The most useful investigation to confirm the diagnosis of DAH con-
sists of bronchial fibroscopy and BAL [1,21]. Bronchoscopy is the most 
direct way to evaluate hemoptysis and determine the site of bleeding (if 
there is an active bleeding) or another obvious cause, such as inhalation 
of a foreign body. A macroscopically hemorrhagic BAL fluid, especially 
with increase blood content on successive aliquots, is considered as a 
diagnostic of acute alveolar hemorrhage (AH). However, the demon-
stration of hemosiderin-laden macrophages (HLMs) is a good evidence 
of sub-acute AH. After a bleeding episode into the lungs, hemoglobin is 
converted to hemosiderin by alveolar macrophages. In a mice model, 
Epstein et al. [14] showed that HLMs and hemosiderin appear within 
48–72h after the initial bleeding, reach a maximal concentration at day 
6 and then remains within the lungs for 4–8 weeks [4]. The Golde score 
is a semi-quantitative assessment of HLMs, after a Prussian blue stain, 
which evaluates both the percentage of macrophages containing he-
mosiderin (evaluating 100 macrophages), and the intensity of staining 
on a scale between 0 and 4. The score can therefore vary from 0 to 400. 
An AH is confirmed for a score above 100 [3]. 
Further investigations of DAH include a search for infectious agents 
and for both precipitating antibodies to cow’s milk proteins and milk- 
specific immunoglobulin E (IgE). Complete work-up should also 
include evaluation for coagulation disorders, screening for a cardiac 
etiology as well as for possible pulmonary-renal syndromes [17,18], 
including urine analysis and renal function, as well as specific serologic 
testing for antinuclear antibodies (ANA) and their components, 
anti-glomerular basement membrane (GBM) antibodies, and anti-
neutrophil cytoplasmic antibodies (ANCA) to detect immune-mediated 
lung disease [18,23]. As the diagnosis of DAH can be performed by 
less invasive procedures, lung biopsy is not justified [21]. 
4. Presentation of the cases 
4.1. Case 1 
A seven-week-old male was admitted to the Pediatric Emergency 
Department after an episode of hemoptysis and epistaxis. He was born 
full term, eutrophic, with normal neonatal adaptation. He was fed with 
cow milk (CM) formula from birth on. No other symptoms preceding the 
hemorrhage were reported by the parents. At the admission, the patient 
presented a bloody nasal discharge. Clothes were stained with blood. He 
was pale and hypotonic. He presented a moderate tachypnea varying 
from 40 to 50 bpm but without associated hypoxemia (SpO2 95% on 
room air). There was no fever, no central cyanosis, the capillary refill 
time was normal, and there were no actively hemorrhagic skin or mu-
cous lesions. The infant was dyspneic with chest retractions and pre-
sented a grunting. The pulmonary auscultation was normal, there were 
neither crackles nor wheezes. The cardiovascular exam and the systemic 
examination were unremarkable. Family and patient history was not 
contributive. Exposure to tobacco smoke or abnormal humidity at home 
were denied. 
Initial routine laboratory results revealed a hemoglobin level of 10.5 
g/dL, a hematocrit value of 22%, a white blood cell count (WBC) of 13.9 
x 10*9/L, a platelet count of 360 x 10*9/L, with normal coagulation 
profile (prothrombin time: 16.6 seconds, activated partial thrombo-
plastin time: 39 seconds, fibrinogen: 2.2 g/L and D-dimers: 760ng/mL). 
C-reactive protein level, renal function, electrolytes, and aminotrans-
ferases were normal. Central venous blood gases showed a moderate 
respiratory acidosis (pH of 7.17, partial pressure of carbon dioxide of 68 
mm Hg). Toxicology screen was negative, and urinalysis was normal. 
The chest radiograph showed diffuse alveolar infiltrates mostly in the 
right lung (Fig. 1a). Chest computed tomography (CT) showed consoli-
dated opacities mainly in the right lung (Fig. 1b). 
Within the first hour of hospitalization, the oxygen saturation 
decreased (SpO2 75%), and the anemia worsened(hemoglobin of 8,5 g/ 
dL); therefore, a supportive therapy including volume expansion, 
ventilatory support, and transfusion of packed red blood cells at a dose 
of 20ml/kg was necessary. The infant was intubated and transported to 
our Pediatric Intensive Care Unit (PICU) under initial antibiotic 
coverage. 
The infant underwent emergency bronchial fibroscopy, and diffuse 
active bleeding [diffuse alveolar hemorrhage (DAH)] was spotted. There 
were large amounts of blood and clots present in the whole airway. 
Unfortunately, it was not possible to perform a bronchoalveolar lavage 
(BAL) because of the hemodynamic instability of the patient. Full etio-
logic assessment was done and was not contributive (see Table 1). The 
diagnosis of idiopathic hemosiderosis was proposed. 
The immunosuppressive therapy was prescribed using 2 mg/kg of 
prednisolone daily. The infant was extubated on day 2, and discharged 7 
days after admission. The infant returned home on steroid therapy 
(2mg/kg/day during one month and followed by a gradual dose 
reduction), with hypoallergenic amino acid-based milk and under home 
cardio-respiratory monitoring. The patient is regularly followed in the 
respiratory outpatient clinic, and he is doing very well. At 3 months of 
age, the chest radiograph and the CT were normalized. 
4.2. Case 2 
A 3-month-old male infant, born at full term, eutrophic, with normal 
neonatal adaptation, presented at the emergency department for cough 
Table 1 
Classification of diffuse alveolar hemorrhage in young infants.  
Classification Disorders 












Antiphospholipid antibody syndrome 
Polymyositis 
Non-immune Disorders (More Common) 
Non-cardiovascular Origins: 
Idiopathic pulmonary hemosiderosis 
Heiner syndrome 




Drugs and toxines 
Cardiovascular Causes: Mitral stenosis 
Pulmonary veno-occlusive disease 
Arteriovenous malformations 
Pulmonary hypertension 
Pulmonary capillary hemangiomatosis 
Chronic right heart failure  
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followed by several episodes of hemoptysis. 
History included hospitalization at the age of two and a half months 
for tachypnea, cough and upper airways congestion accompanied by 
oral bloody secretions. The initial diagnosis was gastroesophageal reflux 
and the patient was discharged from hospital with a proton pump in-
hibitor and a strict cow’s milk elimination. 
On admission, the infant was well perfused, and not hypoxic (SpO2 
98% on room air). Physical examination showed nasal congestion and 
bilateral lung crackles on pulmonary auscultation. No dyspnea was 
noted. Central venous blood gases showed a pH of 7.3 and partial 
pressure of carbon dioxide of 54 mm Hg. Laboratory studies showed 
anemia (hemoglobin level: 8.1 g/dL, hematocrit value: 24%). WBCs and 
platelet count, coagulation profile, quantitative immunoglobulins, and 
complement studies were normal. Urine analysis was normal. 
Chest x-ray revealed bilateral alveolo-interstitial opacities and left 
lower lobe parenchymal consolidation (Fig. 2a). Chest CT showed 
diffuse bilateral alveolar and ground-glass opacities (Fig. 2b). 
The infant received packed red cells but no ventilatory support was 
necessary. A bronchial fibroscopy was performed early after admission 
that active diffuse bleeding was objectified. Due to the precocity of BAL, 
hemosiderin-laden macrophages were not demonstrated in the cyto-
logical analysis. Etiologic assessment was done and was not contributive 
except the presence of Chlamydia Trachomatis on BAL culture (see 
Table 1). The diagnosis of an interstitial pneumonitis with subsequent 
diffuse alveolar hemorrhage was made. Antimicrobial therapy using oral 
clarithromycin 15mg/kg/day for 21 days was given, while the systemic 
corticotherapy initiated at admission was stopped. The patient’s symp-
toms completely resolved shortly after the start of treatment and he was 
discharged from the hospital on the 8th day on hypoallergenic amino 
acid-based milk and with a cardio-respiratory monitor. 
4.3. Case 3 
A two-month-old female infant, born at 37 weeks of gestation from 
consanguineous parents, eutrophic, needed prolonged hospitalization in 
the Neonatal Intensive Care Unit (NICU) for polymalformative syn-
drome including a common atrium, rectovulvar fistula, alopecia, and 
dysmorphic features. Initial adaptation at birth was marginal but she 
quickly stabilize after birth, and a non-invasive ventilatory support was 
needed for mild apneic syndrome. She was found unconscious, apneic, 
bradycardic with a heart rate of 60–70 beats per minute and cyanotic 
(SpO2 40% on room air), with foamy bloody secretions in her mouth and 
nose. No history of trauma, fever or bleeding from any other site was 
noted. 
The acute situation required emergency tracheal intubation and 
fresh blood was aspirated from the endotracheal tube. Heart rate and 
oxygen saturation quickly improved with conventional mechanical 
ventilation. High ventilatory pressures were needed to achieve adequate 
tidal volumes. Physical examination showed normal skin, bilateral lung 
crackles and a systolic murmur already known. Chest radiograph 
showed cardiomegaly with diffuse alveolar infiltrates mostly in the right 
lung. Complete blood count showed normal WBCs count (8500/mm3 
with 22% neutrophils, 69% lymphocytes), a hemoglobin level of 10 g/ 
dl, a hematocrit value of 30.4%, a platelet count of 247,000/mm3, and a 
normal coagulation profile. Central venous blood gases showed mild 
respiratory acidosis and elevated lactate level (50mg/dL). Screening for 
common causes of DAH (see Table 1) was performed but was not 
contributive. 
Two days later, packed red blood cells were transfused for anemia 
and intravenous antibiotics were administered for suspected infection 
(fever and raised inflammatory markers). Blood culture and nasopha-
ryngeal aspiration were obtained for viral and bacterial screening. 
Thoracic angiography scan showed consolidated opacities mainly 
within the right lung, and arteriovenous malformation were excluded 
(Fig. 3a, b). The echocardiography confirmed large inter-atrial left-to- 
right shunt. A bronchial fibroscopy was performed 6 days after admis-
sion, excluding active bleeding. BAL was not performed because of the 
patient’s respiratory instability. 
Fig. 1. (a) Chest radiography showed diffuse alveolar infiltrates mostly in the right pulmonary hemi-field. (b) Chest computed tomography scan showed, within the 
right upper lobe, complete consolidation in the posterior segment and nearly complete consolidation in the anterior segment. 
Fig. 2. (a) Chest radiograph demonstrated bilateral alveolo-interstitial opacities. (b) Chest computed tomography scan showed diffuse bilateral alveolar and ground- 
glass opacities. 
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The first extubation attempt was done on day 3, but reintubation was 
necessary due to the recurrent bleeding episode and respiratory distress. 
The patient initially continued to present fresh blood and clots 
aspirated from her endotracheal tube and then slowly improved from 
day 4 after the first bleeding episode. Her ventilatory support was 
weaned and she was successfully extubated on day 6. Her chest radio-
graph showed significant clearance of the initial haziness. Respiratory 
virus PCR panel from nasopharyngeal aspiration and tracheal secretions 
was positive for coronavirus NL63. Bacterial cultures from respiratory 
secretions and blood were negative. Antimicrobial therapy was stopped 
after 48 hours and the infant received oral corticosteroid treatment. 
4.4. Case 4 
A three-week-old male, born at full term, eutrophic with normal 
neonatal adaptation, was admitted to the emergency department for a 
severe episode of loss of consciousness accompanied by hypotonia and 
cyanosis. The infant, was found unconscious in bed 1 hour after feeding 
on his stomach, surrounded by soft toys and pillows. His mother noticed 
some foamy red secretions on his lips. 
At admission, he was pale, capillary refill time was prolonged (4 
seconds), central temperature was 35.5 ̊C. He showed nasal flaring and 
retractions, a respiratory rate of 40–50 bpm, and SpO2 at room air of 
85%. The pulmonary auscultation revealed bilateral crackles. A venous 
blood gas showed a severe metabolic acidosis (pH: 7.08, partial pressure 
of carbon dioxide: 38 mmHg, bicarbonate: 10 mmol/L and base excess: 
18 mmol/L). Hemoglobin level was normal (16 g/d). Further routine 
laboratory results including markers of inflammation and infection, of 
hemostasis, of renal and hepatic function were normal. Urinalysis was 
also normal. Chest x-ray revealed diffuse and bilateral opacities 
(Fig. 4a). The cardiac evaluation, including echocardiogram, revealed a 
physiologic patent foramen ovale. 
The infant was admitted to the Intensive Care Unit under initial triple 
intravenous antibiotic coverage, non-invasive ventilatory support and 
supplemental oxygen. The first 48 hours of hospitalization, he presented 
a sudden drop of 4 g/dL of the hemoglobin levels. A bronchial fibroscopy 
and a BAL were performed on day 4. No active bleeding was noted. 
Hemosiderin-laden macrophages (siderophages) at 68%, and a positive 
Golde score at 129% were demonstrated in the BAL confirming the DAH. 
Etiologic assessment for DAH was done and was not contributive (see 
Table 1). During hospitalization, he received prednisone 2mg/kg/day 
and he was discharged after one week with the diagnosis of AH probably 
due to accidental suffocation, as he was found lying with his face against 
the mattress. The patient was on steroid treatment with gradual dose 
reduction, with hypoallergenic amino acid-based milk and under cardio- 
respiratory monitoring. 
4.5. Case 5 
A 3-month-old male infant, born at full term, eutrophic, with a his-
tory of transient tachypnea of the newborn after birth, was admitted at 
the emergency department for brutal cough and hemoptysis while 
sleeping. He was described hypotonic during this episode. No symptoms 
were reported by parents preceding the hemorrhage. He was fed with 
cow milk (CM) formula from birth on. 
On admission, the infant was eupneic and normoxic (SpO2 98% on 
room air). Physical examination and in particular the pulmonary 
auscultation was normal. One hour later, he developed dyspnea with 
moderate chest retractions. Central venous blood gases showed a res-
piratory acidosis (pH of 7.08 and partial pressure of carbon dioxide of 
71 mm Hg). Initial laboratory study showed anemia (hemoglobin level: 
9.4 g/dL, hematocrit value: 29.3%), thrombocytosis (platelet count: 
595.000/mm3), hyperleukocytosis (WBC count: 18.530/mm3, 54% 
lymphocytes, 39% neutrophils) but normal C-reactive protein levels. 
Further routine laboratory results including septic, hemostatic, renal, 
and hepatic profile returned normal. Urinalysis was also normal. 
Chest x-ray revealed diffuse interstitial opacities in the right lung 
(Fig. 5a), Thoracic angiography scan confirmed diffuse interstitial 
opacities in the right lung and excluded vascular malformation . 
A bronchial fibroscopy was performed on day 4 after the episode of 
bleeding and did not demonstrate any active bleeding. Hemosiderin- 
laden macrophages (siderophages) at 89%, and a positive Golde score 
at 212% were demonstrated in the BAL, confirming DAH. The infant 
Fig. 3. (a,b) Thoracic angiography scan showed consolidated opacities mainly within the right lung.  
Fig. 4. (a) Chest x-ray showed diffuse alveolar infiltrates.  
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received prednisone 2mg/kg/day. A complete etiologic assessment for 
DAH (see Table 1) was done and was not contributive except for the 
positivity of precipitins against cow’s milk proteins (see Table 3). The 
diagnosis of Heiner syndrome was made. Hypoallergenic amino acid- 
based milk diet was proposed. 
The patient’s evolution during the hospitalization was favorable and 
no subsequent hemoptysis was noted. The patient was discharged from 
hospital with amino acid-based milk and systemic corticosteroid. During 
regular outpatient visits, the patient presented a favorable respiratory 
evolution without any recurrent hemoptysis. The corticosteroid treat-
ment was stopped after three months. 
5. Discussion 
Five cases of DAH are described in this report. Our five patients 
presented episodes of hemoptysis, anemia of varying degrees, and their 
chest radiographs showed diffuse bilateral interstitial infiltrates consis-
tent with pulmonary hemorrhage. Consequently a diagnosis of DAH was 
Fig. 5. (a) Chest radiography showed diffuse alveolar infiltrates at the right 
pulmonary hemifield. 
Fig. 6. Algorithm for management of intra-alveolar haemorrhage 
BAL: bronchoscopic alveolar lavage; RF: rheumatic factor; ANCA: Antineutrophil Cytoplasmic Antibodies; ANA: Antinuclear Antibodies; GBM: Glomerular Base-
ment Membrane. 
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strongly suspected (Fig. 6). In three of the five cases, the severity of the 
initial pulmonary hemorrhage was sufficient to cause acute pulmonary 
distress, requiring adequate ventilatory support and to cause severe 
anemia requiring packed red blood cell transfusion. In all our cases, due 
to young age, systemic vasculitis and collagen vascular disorders were 
unlikely. 
In all cases, pediatric pulmonologists performed a bronchial fibro-
scopy in order to look for active bleeding in the airways. In the absence 
of obvious cause of the bleeding, BAL was performed. Hemosiderin- 
laden macrophages were found in BAL only in 2 of our 5 patients, 
either due to early performance of the BAL within 24 hours from he-
moptysis or due to limitations of the bronchoscopy procedure because of 
hemodynamic instability of the patients. As previously mentioned, 
HLMs were not demonstrated in the cytological analysis until 48–72 
hours after the acute phase. However, the visualization of areas of active 
bleeding, and the aspiration of fresh blood confirmed the pulmonary 
hemorrhage in these cases. 
Table 2 presents bronchoalveolar lavage results for these five cases. 
In all cases, the diagnosis of DAH was confirmed by the bronchos-
copy. Subsequently and in order to identify a specific etiology, we 
proceeded to additional laboratory tests, as well as selected serologic 
and radiographic studies. 
In our first case, as no underlying pathology was found, the diagnosis 
of idiopathic pulmonary hemosiderosis was retained. As previously 
mentioned pulmonary hemosiderosis is a diagnosis of exclusion, based 
on an association of anemia, chest X-ray pulmonary infiltrates and the 
presence of hemosiderin-laden macrophages in the bronchoalveolar 
lavage. Further investigation was non contributive for this infant. 
The next two cases of DAH were due to infectious causes. In our 
second case, culture analysis of tracheal aspirate samples identified the 
presence of Chlamydia Trachomatis. Infants born vaginally from infec-
ted mothers are at risk of acquiring Chlamydia trachomatis, which can 
lead to severe tracheobronchial or pneumonic infection and DAH. In our 
third case, polymerase chain reaction of tracheal aspirate samples 
identified the presence of Coronavirus NL63. Coronavirus is a common 
cause of upper respiratory tract infection in children and has also been 
occasionally associated with lower respiratory tract infections (such as 
bronchiolitis and pneumonia) and with pulmonary hemorrhage [8]. At 
present, there are seven coronaviruses recognized as human pathogens 
(HCoV): HCoV-OC43, HCoV-299E, HCoV-HKU1, HCoV-NL63, SARS 
CoV, MERS-CoV and the newly identified SARS COV-2 [25]. The use of 
reverse transcriptase polymerase chain reaction helps in the rapid and 
reliable detection of these viruses. It is noteworthy, that pulmonary 
hemorrhage in children has been mainly associated with bacterial in-
fections, such as Staphylococcus aureus, in relation to necrotizing 
pneumonia [6], by fungi, such as Stachybotrys Chartarum [11] and 
occasionally by virus such as H1N1 influenza [7]. To our knowledge, our 
patients are the second reported cases of pulmonary hemorrhage in in-
fants associated with chlamydia trachomatis [5] and coronavirus 
infection [8], respectively. 
In our fourth case, mainly according to detailed anamnestic data, 
accidental suffocation and asphyxia were probably the causes of the 
DAH. It is worth mentioning that the infant received an objective eval-
uation including ophthalmologic examination and head imaging 
because of initial suspicion of abuse. Suffocation and shaken baby 
syndrome are the most difficult components to exclude in the differen-
tial diagnosis of pulmonary hemorrhage. 
In our last case, serum immunoglobulin levels (IgG, IgA, IgM, IgE) 
and milk-specific serum IgE were normal but interestingly high precip-
itating cow’s milk proteins antibodies titers was found and Heiner 
syndrome (HS) was diagnosed. Heiner syndrome (HS) is a cow’s milk 
(CM) hypersensitivity pulmonary disease that affects primarily infants. 
Moissidis et al., recently reported a series of infants with recurrent res-
piratory symptoms and iron deficiency anemia. All of these children 
presented symptomatic and radiologic improvement with the eviction of 
cow’s milk proteins [2,13]. 
The immunologic mechanism in milk-induced pulmonary disease is 
incompletely clear. The formation of immune complexes (Gell and 
Coombs’ type III) or cell-mediated reaction (Gell and Coombs’ type IV) 
may have a role. Patients with HS characteristically have high titers of 
milk-specific IgG antibodies (which is not pathognomic of the disease) 
and some of them may have high serum total IgE levels and milk-specific 
IgE antibodies. Although this syndrome remains a controversial entity 
which has been rarely reported in the medical literature, it should be 
particularly suspected in pediatric pulmonary practices. Insufficient 
awareness about this disease is probably a major factor in its misdiag-
nosis and its morbidity. 
Table 3 presents data regarding assessments, diagnosis, and treat-
ment for the five cases presented. 
6. Treatment and prognosis 
In our five cases, none had elevated milk-specific IgE antibodies and 
only one had positive IgG antibodies against CM proteins. However, 
considering the young age of our five patients and the immaturity of the 
infant’s immune system, our policy was to remove cow’s milk from the 
diet of infants and control the serum immunoglobulins levels later in 
life. 
In acute phase, the treatment was symptomatic (transfusion, oxygen 
therapy and, if needed, ventilatory support) for all the patients. For the 
second case we concluded to interstitial pneumonitis and a diffuse 
alveolar hemorrhage due to an infectious agent for which the patient 
received antimicrobial therapy by oral clarithromycin 15mg/kg/day for 
21 days. For all the other cases, the first-line curative treatment was oral 
corticosteroids. Corticosteroids have been reported to be associated with 
decreased pulmonary bleeding relapses and pulmonary fibrosis pro-
gression, as well as with higher survival rates [10]. Since the recom-
mended duration of corticosteroids treatment is variable among the 
patients based on clinical, radiological, and biological evolution, our 
patients received prolonged treatment for 3–6 months [23]. In small 
case series of severe DAH, which does not improve with intravenous 
corticosteroids, the use of intrapulmonary recombinant factor VII a, has 
been described to obtain good results [20]. In chronic cases of pulmo-
nary hemorrhage with poor response to steroids, or in cases associated 
with systemic diseases, immunosuppressive agents such as azathioprine, 
methotrexate, and cyclophosphamide have been used with variable re-
sults [10,16]. 
All of our five cases are followed up closely in respiratory outpatient 
clinic and none of them has had further episodes of pulmonary bleeding 
up to 12 months after discharge. 
Table 2 
Bronchoalveolar lavage results.   
Red blood cells, mm3 White blood cells, mm3 Neutrophils, % Lymphocytes, % Macrophages, % Hemosiderin-laden macrophages, %, Golde score 
Case 1 510 450 ND ND ND ND ND 
Case 2 1910 400 73 4 23 ND ND 
Case 3 1540 110 ND ND ND ND ND 
Case 4 280 450 1.3 1.9 96 69 129 
Case 5 80 460 33 3 63 89 212 
ND: not done. 
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Recent retrospective case studies have shown significantly better 
survival, with five-year survival rates above 80%. Prolonged remission is 
possible; however, later death from the disease remains a possibility [9]. 
The cause of death is generally terminal chronic respiratory failure but 
may also be massive hemoptysis. Sometimes DAH is immune-mediated 
and the prognosis of these patients in terms of morbidity and mortal-
ity may be affected by the extent of involvement in other organs [19]. 
7. Conclusion 
This article focuses on diffuse alveolar hemorrhage in infancy. In 
childhood and mostly in infancy, diffuse alveolar hemorrhage present as 
a rare but serious medical emergency. The differential diagnosis in in-
fants includes cardiopulmonary vascular malformations, infection, 
coagulation disorders, food hypersensitivity syndromes and idiopathic 
pulmonary hemosiderosis. Vasculitis and collagenosis are extremely 
rare in infancy. An early diagnosis is crucial. As highlighted by these 
case reports, high index of suspicion, adequate etiologic screening and 
appropriate treatment are mandatory to improve survival. 
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